These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 15857946

  • 1. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 2. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S, Nyengaard JR, Wogensen L.
    Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
    [Abstract] [Full Text] [Related]

  • 3. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model.
    Ota T, Takamura T, Ando H, Nohara E, Yamashita H, Kobayashi K.
    Diabetologia; 2003 Jun; 46(6):843-51. PubMed ID: 12774163
    [Abstract] [Full Text] [Related]

  • 4. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Jun; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 5. Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart.
    Hilliard LM, Russo LM, Comper WD.
    Am J Nephrol; 2009 Jun; 29(5):454-64. PubMed ID: 19023196
    [Abstract] [Full Text] [Related]

  • 6. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
    Tahira Y, Fukuda N, Endo M, Ueno T, Matsuda H, Saito S, Matsumoto K, Mugishima H.
    J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
    [Abstract] [Full Text] [Related]

  • 7. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y, Fukagawa M.
    Kobe J Med Sci; 2007 Mar; 53(1-2):53-61. PubMed ID: 17582205
    [Abstract] [Full Text] [Related]

  • 8. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.
    Fujita A, Sasaki H, Doi A, Okamoto K, Matsuno S, Furuta H, Nishi M, Nakao T, Tsuno T, Taniguchi H, Nanjo K.
    Diabetes Res Clin Pract; 2008 Jan; 79(1):11-7. PubMed ID: 17897750
    [Abstract] [Full Text] [Related]

  • 9. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 10. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y.
    Diabetes Metab Res Rev; 2006 Jul 28; 22(4):313-22. PubMed ID: 16389646
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.
    Zhang YW, Xie D, Chen YX, Zhang HY, Xia ZX.
    Exp Clin Endocrinol Diabetes; 2006 Nov 28; 114(10):563-8. PubMed ID: 17177138
    [Abstract] [Full Text] [Related]

  • 12. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.
    J Pharmacol Exp Ther; 2006 Jan 28; 316(1):8-16. PubMed ID: 16166267
    [Abstract] [Full Text] [Related]

  • 13. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
    Zhang YW, Xie D, Xia B, Zhen RT, Liu IM, Cheng JT.
    Horm Metab Res; 2006 Feb 28; 38(2):82-8. PubMed ID: 16523407
    [Abstract] [Full Text] [Related]

  • 14. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S, Nakamura T.
    Am J Physiol Renal Physiol; 2004 Jan 28; 286(1):F134-43. PubMed ID: 14519594
    [Abstract] [Full Text] [Related]

  • 15. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S.
    Am J Physiol Renal Physiol; 2007 Nov 28; 293(5):F1657-65. PubMed ID: 17804483
    [Abstract] [Full Text] [Related]

  • 16. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.
    J Nephrol; 2003 Nov 28; 16(6):841-9. PubMed ID: 14736011
    [Abstract] [Full Text] [Related]

  • 17. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Horm Metab Res; 2001 Nov 28; 33(11):664-9. PubMed ID: 11733869
    [Abstract] [Full Text] [Related]

  • 18. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 28; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 19. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H.
    Diabetes; 2007 Feb 28; 56(2):346-54. PubMed ID: 17259378
    [Abstract] [Full Text] [Related]

  • 20. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
    Tomohiro T, Kumai T, Sato T, Takeba Y, Kobayashi S, Kimura K.
    Life Sci; 2007 Mar 20; 80(15):1364-72. PubMed ID: 17331548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.